Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Family Medicine

Clinical Pharmacology

Use of once-weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE Canada multicentre, prospective, observational study

Diabetes, Obesity and Metabolism | Aug 19, 2021 Clinical Pharmacology

Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): A randomized, open-label, parallel-group, phase 3 trial

The Lancet | Aug 18, 2021 Clinical Pharmacology

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: Results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study

Annals of Rheumatic Diseases | Aug 18, 2021 Clinical Pharmacology

Associations of insulin resistance with systolic and diastolic blood pressure: A study from the HCHS/SOL

Hypertension | Aug 18, 2021 Clinical Pharmacology

Relationship of enhanced liver fibrosis score with pediatric non-alcoholic fatty liver disease histology and response to vitamin E or metformin

The Journal of Pediatrics | Aug 18, 2021 Clinical Pharmacology

Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults

Journal of Substance Abuse Treatment | Aug 18, 2021 Clinical Pharmacology

A monoclonal antibody for malaria prevention

New England Journal of Medicine | Aug 17, 2021 Clinical Pharmacology

Clinical impact of medication adherence on 10‐year cardio‐cerebrovascular mortality in newly diagnosed hypertensive patients

The Journal of Clinical Hypertension | Aug 17, 2021 Clinical Pharmacology

Cabotegravir for HIV prevention in cisgender men and transgender women

New England Journal of Medicine | Aug 16, 2021 Clinical Pharmacology

Durability of response to SARS-CoV-2 BNT162b2 vaccination in patients on active anticancer treatment

JAMA | Aug 16, 2021 Clinical Pharmacology

« Prev 1 … 48 49 50 51 52 … 393 Next »

Use of once-weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE Canada multicentre, prospective, observational study

Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): A randomized, open-label, parallel-group, phase 3 trial

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: Results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study

Associations of insulin resistance with systolic and diastolic blood pressure: A study from the HCHS/SOL

Relationship of enhanced liver fibrosis score with pediatric non-alcoholic fatty liver disease histology and response to vitamin E or metformin

Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults

A monoclonal antibody for malaria prevention

Clinical impact of medication adherence on 10‐year cardio‐cerebrovascular mortality in newly diagnosed hypertensive patients

Cabotegravir for HIV prevention in cisgender men and transgender women

Durability of response to SARS-CoV-2 BNT162b2 vaccination in patients on active anticancer treatment

Article: Clinical Guide to Molecular Testing in Bethesda III and IV Nodules for Indian Practice

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes & Urinary ACR: Detecting Kidney Damage Early with Dr Saraogi

New research aims to transform treatments of aggressive blood cancer

Enhanced car T cell therapy offers new strategy for lymphoma

Use of once-weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE Canada multicentre, prospective, observational study

Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): A randomized, open-label, parallel-group, phase 3 trial

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: Results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study

Associations of insulin resistance with systolic and diastolic blood pressure: A study from the HCHS/SOL

Relationship of enhanced liver fibrosis score with pediatric non-alcoholic fatty liver disease histology and response to vitamin E or metformin

Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults

A monoclonal antibody for malaria prevention

Clinical impact of medication adherence on 10‐year cardio‐cerebrovascular mortality in newly diagnosed hypertensive patients

Cabotegravir for HIV prevention in cisgender men and transgender women

Durability of response to SARS-CoV-2 BNT162b2 vaccination in patients on active anticancer treatment

Article: Clinical Guide to Molecular Testing in Bethesda III and IV Nodules for Indian Practice

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes & Urinary ACR: Detecting Kidney Damage Early with Dr Saraogi

New research aims to transform treatments of aggressive blood cancer

Enhanced car T cell therapy offers new strategy for lymphoma

Select Specialty

Select Topic